Patient-reported outcomes in patients co-infected with hepatitis C virus and human immunodeficiency virus treated with sofosbuvir and velpatasvir: The ASTRAL-5 study.
about
Patient-reported outcomes in patients co-infected with hepatitis C virus and human immunodeficiency virus treated with sofosbuvir and velpatasvir: The ASTRAL-5 study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Patient-reported outcomes in p ...... lpatasvir: The ASTRAL-5 study.
@en
type
label
Patient-reported outcomes in p ...... lpatasvir: The ASTRAL-5 study.
@en
prefLabel
Patient-reported outcomes in p ...... lpatasvir: The ASTRAL-5 study.
@en
P2093
P2860
P356
P1433
P1476
Patient-reported outcomes in p ...... lpatasvir: The ASTRAL-5 study.
@en
P2093
Maria Stepanova
Mark Sulkowski
Sharon Hunt
Zobair M Younossi
P2860
P356
10.1111/LIV.13462
P577
2017-05-04T00:00:00Z